The Valley Desk

NCT04468061 · Interventional trial

Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC

Overall registry status Recruiting

Phase 2

Conditions Breast Cancer, PD-L1 Negative, Triple Negative Breast Cancer

Delaware Valley sites

First posted

Registry updated

Added to the directory

View this study on ClinicalTrials.gov